Delving into Crohn’s disease post-ileocolic resection, this meta-analysis (17 studies, 2087 patients) compares anastomotic techniques. Endoscopic postoperative recurrence (epor) risk at ≥6 months was 37.2%. Kono-S anastomosis (17.7% cases) outshone conventional methods (81% cases), showing a lower epor incidence (24.7% vs. 42.6%). Results suggest Kono-S reduces epor risk, emphasizing its potential for challenging cases. While […]
Category: General Surgery
Cracking the Code: Gastrojejunal Anastomosis Holds Clues to Weight Regain in Gastric Bypass Graduates
Researchers delved into the post-gastric bypass world, unraveling the mystery of weight regain (WR). Examining 34 Roux-en-Y gastric bypass alumni, they discovered a correlation between the gastojejunal anastomosis (GJA) diameter and WR. However, excluding outliers with GJA over 30 mm nullified the link. The study highlights the potential of visual GJA estimation and emphasizes that […]
Robotic Surgery Linked to Lower Postoperative Infections and Shorter Hospital Stays in Pancreatoduodenectomy
In a retrospective study spanning 2013 to 2022, researchers delved into healthcare-associated infections (HAIs) post-pancreatoduodenectomy (PD). Among 2632 patients, HAIs decreased over time, especially in open PD (OPD). Robotic PD (RPD) exhibited significantly fewer HAIs (5.8% vs. 9.6% in OPD). RPD correlated with reduced infections, shorter hospital stays, and higher costs. Notably, attention should be […]
Gallbladder Polyps: Size Matters in Predicting Cancer Risk
In this cohort study on 438 patients with gallbladder polyps (GPs), the risk of gallbladder cancer was 0.7% for all polyps, escalating to 5.9% for those ≥10 mm. GP size emerged as the sole predictor of malignancy (p = 0.0001), with a 21 mm cutoff indicating cancer risk. Patient’s age, symptoms, number of polyps, and […]
Big Data Shapes Future of Hepatopancreatobiliary Cancer Surgery
In the realm of surgical oncology, randomized controlled trials (RCTs) often face recruitment and standardization challenges. This study dives into hepatopancreatobiliary (HPB) cancer surgery, spotlighting the pivotal role of large databases. While RCTs provide crucial evidence, big data steps in where they fall short. Beyond justifying current practices, this research maps the future of HPB […]
Survival in the Spotlight: 3-Year Encore for TPF Therapy in Esophageal Cancer
Researchers belted out a 3-year follow-up tune on the NEOCRTEC-1601 stage, where docetaxel, cisplatin, and fluorouracil (TPF) took the spotlight. For those with borderline-resectable esophageal squamous cell carcinoma (BR-ESCC), the act featured 54.4% survival rates at the 3-year mark. Surgery danced into the spotlight for 57.4% of patients, confirming TPF’s encore as a promising rhythm […]
Omentectomy Dilemma: Radical Move or Not for Gastric Cancer?
Researchers staged a retrospective showdown between total omentectomy (TO) and partial omentectomy (PO) in the radical gastrectomy arena for advanced gastric cancer (AGC) with serosal invasion. The verdict? No VIP pass for TO in preventing peritoneal recurrence. PO stole the spotlight with comparable recurrence-free survival and a better 5-year overall survival. Turns out, for T4a […]
RoboSlim: Navigating Bariatric Revisions with Robotics
In the quest for post-bariatric excellence, researchers dived into the robotic realm for revisional bariatric surgery (RBS). Surveying 106 patients who embarked on this robotic journey, the results spoke volumes. With a focus on patients experiencing insufficient weight loss, the team uncovered a success story—significant weight loss, improved comorbidities, and relieved symptoms. The RoboSlim saga […]
Hepatic Vagotomy: A Lipid Makeover for Obesity
In the battle against the expanding empire of obesity, researchers delved into hepatic vagotomy’s (HV) potential to rewrite the cholesterol story. Following laparoscopic sleeve gastrectomy, the HV squad at the six-month checkpoint showcased a significant victory with lower total cholesterol/high-density lipoprotein (TC/HDL) ratios. While not all hypotheses stood strong, the study unveiled a promising narrative […]
Cholangiocarcinoma Unveiled: Early-Onset Warriors’ Triumph
In the epic battle against cholangiocarcinoma, researchers scoured the SEER database (1975-2020) for insights. Early-onset warriors (EOC), comprising 274 out of 4037 fighters, emerged with a distinct profile—often non-white, intrahepatic warriors. Despite facing a more advanced enemy at diagnosis, EOCs defied the odds. They opted for surgery, radiotherapy, and chemotherapy, influencing their fate. Cox analysis […]